文献速递肺外科

混合实践中等手术量医院中电视辅助胸腔镜手术与开胸手术治疗肺癌的结果:一项倾向性匹配研究

Results of video-assisted thoracoscopic surgery versus thoracotomy for lung cancer in a mixed practice medium-volume hospital: a propensity-matched study.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2023-01-01

该回顾性队列研究纳入2000—2020年芬兰奥卢大学医院670例以治愈为目的的肺癌患者(VATS组207例,开胸组463例),经倾向性匹配后形成127对。匹配队列中,VATS与开胸的5年总生存率(64.3% vs 63.2%,P=0.969)和5年疾病特异性生存率(71.6% vs 76.2%,P=0.559)均无显著差异;VATS组平均住院时间更短(5.8 vs 6.6天,P=0.012),但中位淋巴结检出数更低(4.0 vs 7.0,P<0.001)。作者结论认为,在混合实践中两种术式的肺癌手术长期结果相当。

要点

  • 匹配队列中VATS与开胸的5年总生存率(64.3% vs 63.2%,P=0.969)无显著差异。
  • 5年疾病特异性生存率VATS组71.6% vs 开胸组76.2%(P=0.559),无显著差异。
  • VATS组平均住院时间更短(5.8 vs 6.6天,P=0.012),中位淋巴结检出数更低(4.0 vs 7.0,P<0.001)。

核心结论

  • 在混合实践的中等手术量中心,VATS与开胸肺癌手术的长期结果相当。

研究设计与样本

  • 回顾性队列研究,纳入2000—2020年奥卢大学医院670例以治愈为目的的肺癌患者,VATS组207例、开胸组463例。
  • 采用倾向性评分匹配,以手术技术为因变量,年龄、性别、Charlson合并症指数、肺功能、病理分期、组织学类型和手术年份为协变量,匹配后形成127对。

主要发现

  • 匹配队列中,VATS组5年总生存率为64.3%,开胸组为63.2%(P=0.969)。
  • VATS组5年疾病特异性生存率为71.6%,开胸组为76.2%(P=0.559)。
  • VATS组总体术后并发症发生率为34.6%,开胸组为44.9%(P=0.096);主要术后并发症发生率VATS组为8.7%,开胸组为14.2%(P=0.167)。
  • VATS组平均住院时间为5.8天,开胸组为6.6天(P=0.012)。
  • VATS组中位淋巴结检出数为4.0枚,开胸组为7.0枚(P<0.001)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to compare the short- and long-term results of video-assisted thoracoscopic surgery (VATS) and thoracotomy for non-small-cell lung cancer in a medium-volume centre, where cardiothoracic surgeons perform both cardiac and general thoracic surgery. The primary outcome of interest was 5-year overall survival and disease-specific survival. Secondary outcomes were short-term postoperative complications, length of hospital stay and lymph node yield. METHODS: This was a retrospective cohort study including 670 lung cancer patients undergoing VATS (n = 207) or open surgery (n = 463) with a curative intent in Oulu University Hospital between the years 2000-2020. Propensity score matching was implemented with surgical technique as the dependent and age, sex, Charlson comorbidity index, pulmonary function, pathological stage, histological type and the year of the operation as covariates resulting in 127 pairs. RESULTS: In the propensity-matched cohort, 5-year overall survival was 64.3% after VATS and 63.2% after thoracotomy (P = 0.969). Five-year disease-specific survival was 71.6% vs 76.2% (P = 0.559). There were no differences in overall (34.6% vs 44.9%, p = 0.096) or major postoperative complications (8.7% vs 14.2%, P = 0.167) between the study groups. The average length of hospital stay was shorter (5.8 vs 6.6 days, P = 0.012) and the median lymph node yield was lower (4.0 vs 7.0, P < 0.001) in the VATS group compared to the thoracotomy group. CONCLUSIONS: According to this study, the long-term results of lung cancer surgery in a mixed practice are comparable between VATS and open surgery.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Niskakangas A, Mustonen O, Puro I, et al. Results of video-assisted thoracoscopic surgery versus thoracotomy for lung cancer in a mixed practice medium-volume hospital: a propensity-matched study. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 38011678. doi:10.1093/icvts/ivad189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。